Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
US-12428410-B2 · Sep 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Feinberg Mark patents
Feinberg Mark is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Feinberg Mark |
| Total patents | 6 |
| First publication | May 4, 2017 |
| Latest publication | Sep 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins
US-12311021-B2 · May 27, 2025 · US
Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy
US-2022185801-A1 · Jun 16, 2022 · US
Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
US-11267807-B2 · Mar 8, 2022 · US
Vaccine Compositions For Preventing Coronavirus Disease
US-2021338804-A1 · Nov 4, 2021 · US
Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy
US-2017121318-A1 · May 4, 2017 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Brigham & Womens Hospital Inc | 4 |
| Beth Israel Deaconess Medical Ct Inc | 3 |
| Int Aids Vaccine Initiative Inc | 2 |
| Merck Sharp & Dohme | 1 |
| Merck Sharp & Dohme Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07C217/48 | 4 |
| C07C205/45 | 4 |
| C07C39/15 | 4 |
| C07C49/84 | 4 |
| C07C251/86 | 4 |